Status:
UNKNOWN
The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation
Lead Sponsor:
Bayside Health
Collaborating Sponsors:
The Alfred
Monash University
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
16-70 years
Brief Summary
Gastro-oesophageal reflux (GOR) has been found to be prevalent in children with cystic fibrosis (CF)and may further worsen lung damage via reflex bronchospasm or pulmonary aspiration. Chest physiother...
Detailed Description
A factorial longitudinal study will be undertaken in adults with cystic fibrosis. Results will be compared with age matched healthy controls. It is not deemed appropriate to randomise patients with ga...
Eligibility Criteria
Inclusion
- \* Diagnosis of cystic fibrosis
- Medically stable
Exclusion
- \* Known oesophageal varices
Key Trial Info
Start Date :
February 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00164021
Start Date
February 1 2001
Last Update
January 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Alfred Hospital
Melbourne, Victoria, Australia, 3004